Avastin ratings & reviews

Bevacizumab
Company: Genentech
Brand: Avastin
Drug class: Sensory Organs
+7 more
Sensory Organs, Antineoplastic and Immunomodulating Agents, Ophthalmologicals, Antineoplastics, Wet AMD Treatment Agents, Antineoplastic Monoclonal Antibodies, Antineoplastic Monoclonal Antibodies Targeting Growth Factor Receptors and their Ligands, Antineoplastic Monoclonal Antibodies Targeting VEGF

Sermo AI Overview

  • Despite some skepticism regarding Avastin's efficacy, patients and providers note its safety and tolerability, indicating it is still a trusted option in challenging cancer scenarios, such as inoperable tumors.
  • Adherence to Avastin varies among different cancer types, with high adherence in ovarian cancer but notable inconsistency in adherence noted among specialists treating colorectal and cervical cancers and glioblastoma.
  • Avastin is generally seen as effective, particularly in ovarian cancer, where it shows high adherence among specialists. However, variability exists across other cancer types, like renal cell and glioblastoma, which receive lower efficacy ratings from some physicians.
  • While Avastin demonstrates perceived usefulness in hepatocellular cancer treatment, cost concerns and inconsistent use by specialists hinder its uptake in colorectal cancer and cervical cancer cases.
Based on insights from Sermo’s triple verified physicians

Description

Avastin is the brand name for bevacizumab, a vascular endothelial growth factor inhibitor. The drug is provided as a sterile, preservative-free injection in a solution form for intravenous use, containing either 100 mg/4 mL or 400 mg/16 mL of bevacizumab. Key inactive ingredients include trehalose dihydrate, polysorbate 20, and sodium phosphate buffers.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

This medication is injected into a vein. It is given by your care team in a hospital or clinic setting. Talk to your care team the use of this medication in children. Special care may be needed.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible: -Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat -Bleeding—bloody or black, tar-like stools, vomiting blood or brown material that looks like coffee grounds, red or dark brown urine, small red or purple spots on skin, unusual bruising or bleeding -Blood clot—pain, swelling, or warmth in the leg, shortness of breath, chest pain -Heart attack—pain or tightness in the chest, shoulders, arms, or jaw, nausea, shortness of breath, cold or clammy skin, feeling faint or lightheaded -Heart failure—shortness of breath, swelling of the ankles, feet, or hands, sudden weight gain, unusual weakness or fatigue -Increase in blood pressure -Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell -Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded -Kidney injury—decrease in the amount of urine, swelling of the ankles, hands, or feet -Stomach pain that is severe, does not go away, or gets worse -Stroke—sudden numbness or weakness of the face, arm, or leg, trouble speaking, confusion, trouble walking, loss of balance or coordination, dizziness, severe headache, change in vision -Sudden and severe headache, confusion, change in vision, seizures, which may be signs of posterior reversible encephalopathy syndrome (PRES) Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome): -Back pain -Change in taste -Diarrhea -Dry skin -Increased tears -Nosebleed

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions: -Blood clots -Coughing up blood -Having or recent surgery -Heart failure -High blood pressure -History of a connection between 2 or more body parts that do not usually connect (fistula) -History of a tear in your stomach or intestines -Protein in your urine -An unusual or allergic reaction to bevacizumab, other medications, foods, dyes, or preservatives -Pregnant or trying to get pregnant -Breast-feeding

What may interact with this medication?

Interactions are not expected.

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication. You may need blood work while taking this medication. This medication may make you feel generally unwell. This is not uncommon as chemotherapy can affect healthy cells as well as cancer cells. Report any side effects. Continue your course of treatment even though you feel ill unless your care team tells you to stop. This medication may increase your risk to bruise or bleed. Call your care team if you notice any unusual bleeding. Before having surgery, talk to your care team to make sure it is ok. This medication can increase the risk of poor healing of your surgical site or wound. You will need to stop this medication for 28 days before surgery. After surgery, wait at least 28 days before restarting this medication. Make sure the surgical site or wound is healed enough before restarting this medication. Talk to your care team if questions. Talk to your care team if you may be pregnant. Serious birth defects can occur if you take this medication during pregnancy and for 6 months after the last dose. Contraception is recommended while taking this medication and for 6 months after the last dose. Your care team can help you find the option that works for you. Do not breastfeed while taking this medication and for 6 months after the last dose. This medication can cause infertility. Talk to your care team if you are concerned about your fertility.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence